CONSULTING AGREEMENTConsulting Agreement • March 28th, 2024 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
Contract Type FiledMarch 28th, 2024 Company Industry JurisdictionThis Consulting Agreement (herein referred to as “Agreement”) is made and entered into on December 13, 2022, effective as of January 1, 2023 (the “Effective Date”), by and between Monopar Therapeutics Inc. (herein referred to as “Monopar”), a Delaware corporation, located at 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091, and pRx Consulting, LLC (herein referred to as pRx), a Delaware corporation located at # (each herein referred to as “Party” and collectively as “Parties”).
CONSULTING AGREEMENTConsulting Agreement • March 23rd, 2023 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
Contract Type FiledMarch 23rd, 2023 Company Industry JurisdictionThis Consulting Agreement (herein referred to as “Agreement”) is made and entered into on December 13, 2021, effective as of January 1, 2022 (the “Effective Date”), by and between Monopar Therapeutics, Inc. (herein referred to as “Monopar”), a Delaware corporation, located at 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091, and pRx Consulting, LLC (herein referred to as pRx), a Delaware corporation located at # (each herein referred to as “Party” and collectively as “Parties”).
CONSULTING AGREEMENTConsulting Agreement • March 27th, 2020 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
Contract Type FiledMarch 27th, 2020 Company Industry JurisdictionThis Consulting Agreement (herein referred to as “Agreement”) is made and entered into on January 2, 2019, effective as of January 1, 2019 (the “Effective Date”), by and between Monopar Therapeutics, Inc. (herein referred to as “Monopar”), a Delaware corporation, located at 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091, and pRx Consulting, LLC (herein referred to as pRx), a Delaware corporation located at # (each herein referred to as “Party” and collectively as “Parties”).